Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion type Assertion NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_head.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion description "[In the replication data set high expression of GADD45G was significantly associated with a 2.09-fold (95% CI 1.08-6.14, p = 0.034) increased risk of recurrence while high CARD9, NCF2 and CIITA expression was significantly associated with a 2.52-fold (95% CI 1.24-5.12, p = 0.010), 2.26-fold (95% CI 1.12-4.58, p = 0.023) and 2.11-fold (95% CI 1.05-4.27, p = 0.037) increased risk of death, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_provenance.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion evidence source_evidence_literature NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_provenance.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion SIO_000772 21944129 NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_provenance.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion wasDerivedFrom befree-20150227 NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_provenance.
- NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_assertion wasGeneratedBy ECO_0000203 NP855817.RA9bziuCnQ9Nk6d731CA5nM3_M8ZhhWtcr0DoxWyirhL4130_provenance.